








Neuronal activity-dependent local activation of dendritic unfolded protein response 
promotes expression of brain-derived neurotrophic factor in cell soma. 
 
（樹状突起における神経活動依存的な小胞体ストレス応答の活性化は細胞体における
brain-derived neurotrophic factor の発現を誘導する） 
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The endoplasmic reticulum (ER) is a cellular organelle, responsible for synthesis, folding 
and posttranslational modifications of secretory proteins. Various cellular stress conditions 
lead to accumulation of unfolded proteins in ER lumen. These abnormalities are collectively 
termed ER stress. Eukaryotic cells adapt to ER stress by producing signals dealing with 
unfolded proteins, referred as the unfolded protein response (UPR). In mammalian cells, the 
three major canonical branches of UPR are activated by ER-resident transducers 
inositol-requiring kinase 1 (IRE1), protein kinase R-like ER kinase (PERK) and activating 
transcription factor 6 (ATF6). Of the three transducers, IRE1 has endonuclease activity in its 
cytoplasmic domain and is phosphorylated in response to ER stress. The phosphorylated 
IRE1 triggers non-conventional splicing of x-box binding protein 1 Xbp1 mRNA to mature 
Xbp1 mRNA (spliced Xbp1; Xbp1s), generating XBP1s transcription factor. Recent reports 
suggest that XBP1 plays roles not only in adjusting ER dysfunctions via expressions of target 
genes including molecular chaperones, but also in driving neurite outgrowth and memory 
formation through the expression of neuronal activity-related genes such as brain-derived 
neurotrophic factor (BDNF). However, the activation mechanisms for XBP1 to manage 
neuronal homeostasis in physiological conditions, and the neuronal activity-dependent 
transcriptional regulation of BDNF are unexplored. Here, we demonstrated that glutamate 
induced excitatory synaptic activation accelerates local activation of IRE1-XBP1 pathway in 
distal dendrites, followed by increased BDNF transcription in soma. BDNF in turn drove 
positive feedback loop, eventually orchestrating dendritic outgrowth. 
 
Results and Conclusion 
Previous studies have reported that treatment of neurons with glutamate, an excitatory 
neurotransmitter, induces ER stress. Thus, we tested whether IRE1-XBP1 pathway is 
activated in response to excitatory synaptic activation. Primary cultured mouse hippocampal 
neurons treated with glutamate exhibited the temporal increase in phosphorylated IRE1 and 
Xbp1s mRNA. Immunofluorescence staining analysis showed that IRE1 localized in 
microtubule-associated protein 2 (MAP2)-positive dendritic neurites and in postsynaptic 
density protein 95 (PSD95; postsynaptic marker)-positive punctate sites existing 
neighboring dendritic neurites. Although phosphorylated IRE1 was undetectable under 
normal conditions, the level was drastically increased in the punctate sites overlapped with 
immunoreactivities of PSD95 after glutamate stimulation. Significant increase in 
immunoreactivities of phosphorylated IRE1 was not found in MAP2-positive neurites, 
suggesting that IRE1 is activated in postsynaptic sites in response to glutamate stimulation. 
Next, we examined whether the activated IRE1 in postsynaptic sites promotes accumulation 
of XBP1s in the nucleus. In hippocampal neurons infected with lentiviruses expressing 
scrambled shRNA, XBP1s accumulated into the nucleus following glutamate treatment. The 
accumulation was canceled by the infection of lentiviruses expressing Ire1 shRNA, 
indicating that glutamate enhances XBP1s accumulation in the nucleus via IRE1 
phosphorylation.  
We further investigated the roles of glutamate-induced XBP1s in regulating neuronal 
functions. It has reported that XBP1 is involved in expression of BDNF, a key component in 
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construction of neural network. Other studies have suggested that excitatory synaptic 
activation fine-tunes neurite outgrowth and synaptic plasticity, responsible for construction 
of neural network. Therefore, we speculated that IRE1-XBP1 cascade induced by excitatory 
synaptic activation orchestrates neuronal activities via expression of BDNF. We noticed that 
putative XBP1s-binding site (unfolded protein response element; UPRE) is included in Bdnf 
promoter region. Neuro-2A cells (murine neuroblastoma cells) transfected with Bdnf 
promoter-luciferase construct (BDNF-Luc) showed the increase in the luciferase reporter 
activities after glutamate stimulation. The induction was inhibited by the knockdown of Ire1. 
Transfection with BDNF-Luc lacking UPRE core also canceled the induction of luciferase 
activities. These data indicate that glutamate-induced IRE1-XBP1 pathway directly 
up-regulates BDNF expression through the binding of XBP1s to UPRE core in Bdnf 
promoter.  
BDNF is known to drive its own expression during construction of neural network. Our 
data and the previous reports let us hypothesize that BDNF drives positive feedback loop via 
IRE1-XBP1 pathway to acquire substantial effects on regulation of neuronal functions. 
Hence, we examined whether BDNF activates IRE1-XBP1 signaling in hippocampal neurons. 
Treatment with BDNF induced IRE1 phosphorylation and splicing of Xbp1 mRNA. The other 
canonical UPR branches were not activated after BDNF treatment. It is known that BDNF 
activates diverse signaling modules including protein kinase A (PKA) signaling, which 
maintains neuronal activities. Previous studies have shown that PKA directly binds to the 
cytosolic sites of IRE1, subsequently promoting phosphorylation of IRE1 without luminal 
events of ER. We found that the phosphorylation of p38 MAPK, which is phosphorylated by 
PKA, was elevated in hippocampal neurons exposed to BDNF. The treatment with PKA 
inhibitor H89 attenuated the BDNF-induced phosphorylation of p38 MAPK. The increase in 
phosphorylated IRE1 and Xbp1s was also canceled by H89, suggesting that BDNF induces 
IRE1-XBP1 pathway via PKA activation. Neuro-2A cells transfected with BDNF-Luc showed 
the induction of luciferase activities by BDNF treatment. Treatment with H89 reduced the 
luciferase activities in these cells. Knockdown of Ire1 inhibited the binding of XBP1s to 
UPRE core in Bdnf promoter in the cells treated with BDNF. Collectively, BDNF drives 
positive feedback loop via PKA-IRE1-XBP1 cascade. We next monitored the dendritic 
expansion in hippocampal neurons treated with BDNF and H89. Sufficient expansion of 
MAP2-positive neurites was observed in neurons treated with BDNF. The expansion was 
suppressed by treatment with H89 or Ire1 knockdown. In conclusion, the synergistic 
augmentation of BDNF signaling through PKA-IRE1-XBP1 cascade is critical for substantial 
dendritic outgrowth.  
Our findings reveal a novel mechanism for neuronal activity-dependent activation of 
IRE1-XBP1 pathway in distal dendrites. The output retrogradely propagate into the soma 
for inducing Bdnf. BDNF in turn drive a positive feedback loop via PKA-IRE1-XBP1 cascade 
to orchestrate dendritic outgrowth. 
 
 
 
 
